Biotechnology in the US - Industry Risk Rating Report

IBISWorld
January 27, 2014
25 Pages - SKU: IBSS5205080
Countries covered: United States

Biotechnology in the US - Industry Risk Rating Report

IBISWORLD INDUSTRY RISK RATINGS REPORT

This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'.

The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks arising from the expected future performance of the industry (growth risk) and risk arising from forces external to the industry (external sensitivity risk).

This approach is new in that it analyses non-financial information surrounding each industry. Industries are scored on a 9-point scale, where 1 represents the lowest risk and 9 the highest. The Industry Risk score measures expected Industry Risk over the coming 12-18 months.

Industry Definition

Firms in this industry primarily use living organisms or molecular and cellular techniques to provide chemicals, food and services that meet human needs. The industry excludes companies primarily involved in developing small-molecule pharmaceuticals, performing contract research or manufacturing biological equipment.

Report Contents

Risk Overview

The Risk Overview chapter includes sections on Industry Definition and Activities, Industry Risk Score and Risk Rating Analysis. The Industry Definition and Activities section provides a detailed definition of the activities carried out by operators in this industry as defined in NAICS. A list of the primary activities of the industry is also included. The Industry Risk Score section provides the Overall Industry Risk Score as well as the Risk Scores for each of the three types of risk covered that combine to form the Overall Industry Risk Score. These three types of risk are Structural Risk, Growth Risk and External Sensitivity Risk. The Risk Rating Analysis section discusses the underlying factors contributing to the Overall Industry Risk Score.

Structural Risk

The Structural Risk chapter looks at risk arising from within the industry itself and provides a detailed discussion of the industry’s level of exposure to seven key indicators. These key indicators are Barriers to Entry, Competition, Industry Exports, Industry Imports, Level of Assistance, Life Cycle Stage and Volatility of Industry. The Overall Structural Risk Score is a weighted aggregation of these seven key indicators. Each of the key indicators is discussed in detail in this section.

Growth Risk

The Growth Risk chapter looks at risks arising from the expected future performance of the industry. The Overall Growth Risk Score is determined by amalgamating the scores for Recent Industry Growth and Forecast Industry Growth. Detailed analysis is provided discussing the reasons for the growth scores of both.

Sensitivity Risk

The Sensitivity Risk chapter looks at risks arising from forces (sensitivities) external to the industry. The Overall External Sensitivity Risk Score is determined by identifying the most significant (up to 6) external factors and weighting them to represent how significant each sensitivity is to the performance of the industry. Examples of External Sensitivities are Exchange Rates, Interest Rates, Commodity Prices and Government Regulations. There is also a detailed analysis of the affect each of the sensitivities has on the industry, including charts and data tables where appropriate.

Industry Risk and Industry Risk Scoring Methodology

This chapter provides an overview of how IBISWorld defines Industry Risk and discusses the methodology used to arrive at an Industry Risk Score. There is also a table that provides a definition of the seven levels of Industry Risk.

Biotechnology in the US
62151 - Diagnostic & Medical Laboratories in the US
32531 - Fertilizer Manufacturing in the US
31111 - Animal Food Production in the US
31191 - Snack Food Production in the US
33911a - Medical Instrument & Supply Manufacturing in the US
33911b - Glasses & Contact Lens Manufacturing in the US
54171 - Scientific Research & Development in the US
54194 - Veterinary Services in the US



More Biopharmacology reports by IBISWorld

Biotechnology in the US - Industry Market Research Report by IBISWorld
Biotechnology in the USDemand for cutting-edge medicines and treatments will result in strong growth for the Biotechnology industry. While it was not entirely immune to ...
Biotechnology in Australia - Industry Market Research Report by IBISWorld
Biotechnology in AustraliaBiotechnology is the application of science and technology to living organisms and also parts, products and models thereof, to alter living or non-living ...
See all reports like this >>

More United States Biopharmacology reports

Biotechnology Product Manufacturing by First Research, Inc.
Biotechnology Product ManufacturingBrief Excerpt from Industry Overview Chapter:Companies in this industry manufacture drugs, therapies, vaccines, genetically modified food and fuel, and other products based on ...
Biotechnology in the US - Industry Market Research Report by IBISWorld
Biotechnology in the USDemand for cutting-edge medicines and treatments will result in strong growth for the Biotechnology industry. While it was not entirely immune to ...
United States Market for Psoriatic Arthritis Pharmacotherapy by Frost & Sullivan
This research service covers the United States psoriatic arthritis pharmaceuticals market from 2009 to 2017, with 2011 as the base year. The focus of this ...
United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis by Aruvian's R'search
The rapidly emerging biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 1,020  
    Global Site License  USD 2,550  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!